Offering next day results, DermSTAT™ Skin Infection DNA Panels testing for bacterial, viral, mycotic infections and scabies infestation are more accurate than conventional testing methods.
LEXINGTON, Mass. — StrataDx, a national diagnostic laboratory led by dermatopathology experts, announced the launch of DermSTAT™- Skin Infection DNA Tests. DermSTAT offers next day results on panels developed to detect and differentiate the causative agents on a spectrum of dermatologic skin infections.
When compared to current diagnostic testing methods, including culture, histopathology and KOH, StrataDx’s DermSTAT provides a rapid, accurate and simple diagnostic testing suite with the highest sensitivity and specificity.
DermSTAT Skin Infection DNA Testing Suite:
| Bacterial | Viral | Mycosis | Scabies | Web Space |
| Staphylococcus aureus Streptococcus pyogenes (Group A Streptococcus) mecA gene detection (methicillin resistance) | Herpes Simplex Virus (HSV-1) Herpes Simplex Virus (HSV-2) Varicella Zoster Virus (VZV) | Pan-Dermatophytes Candida spp Malassezia spp | Sarcoptes scabiei Co/Secondary Infection options: -Bacterial Panel -Mycosis Panel | Pan-Dermatophytes Candida spp Corynebacterium minutissimum Pan gram-negative bacteria Staphylococcus aureus* *If positive, reflex to mecA (methicillin resistance) |
“I am excited to offer this unique innovative molecular test to clinicians in order to more quickly and accurately diagnose skin infections,” said Dr. Lisa Cohen, StrataDx’s Managing Director and Associate Dermatopathologist. “With next-day results, DermSTAT enables effective initial therapy and quicker patient management.”
The collection method is a simple skin scraping, submitted for testing in a skin collection pack. The collection process requires little to no post procedure wound care, increasing patient satisfaction. By using StrataDx’s DermSTAT, clinicians also eliminate other time consuming in-office procedures to allow for more time focused on patient care.
Click here to get started and for more information.
